15 research outputs found
Gradual not sudden change: multiple sites of functional transition across the microvascular bed
In understanding the role of the neurovascular unit as both a biomarker and target for disease interventions, it is vital to appreciate how the function of different components of this unit change along the vascular tree. The cells of the neurovascular unit together perform an array of vital functions, protecting the brain from circulating toxins and infection, while providing nutrients and clearing away waste products. To do so, the brain’s microvasculature dilates to direct energy substrates to active neurons, regulates access to circulating immune cells, and promotes angiogenesis in response to decreased blood supply, as well as pulsating to help clear waste products and maintain the oxygen supply. Different parts of the cerebrovascular tree contribute differently to various aspects of these functions, and previously, it has been assumed that there are discrete types of vessel along the vascular network that mediate different functions. Another option, however, is that the multiple transitions in function that occur across the vascular network do so at many locations, such that vascular function changes gradually, rather than in sharp steps between clearly distinct vessel types. Here, by reference to new data as well as by reviewing historical and recent literature, we argue that this latter scenario is likely the case and that vascular function gradually changes across the network without clear transition points between arteriole, precapillary arteriole and capillary. This is because classically localized functions are in fact performed by wide swathes of the vasculature, and different functional markers start and stop being expressed at different points along the vascular tree. Furthermore, vascular branch points show alterations in their mural cell morphology that suggest functional specializations irrespective of their position within the network. Together this work emphasizes the need for studies to consider where transitions of different functions occur, and the importance of defining these locations, in order to better understand the vascular network and how to target it to treat disease
Genetic mapping of APP and amyloid-β biology modulation by trisomy 21
Individuals who have Down syndrome (DS) frequently develop early onset Alzheimer's disease (AD), a neurodegenerative condition caused by the build-up of aggregated amyloid-β and tau proteins in the brain. Amyloid-β is produced by amyloid precursor protein (APP), a gene located on chromosome 21. People who have Down syndrome have three copies of chromosome 21 and thus also an additional copy of APP; this genetic change drives the early development of Alzheimer's disease in these individuals. Here we use a combination of next-generation mouse models of Down syndrome (Tc1, Dp3Tyb, Dp(10)2Yey and Dp(17)3Yey) and a knockin mouse model of amyloid-β accumulation (AppNL-F ) to determine how chromosome 21 genes, other than APP, modulate APP/amyloid-β in the brain when in three copies. Using both male and female mice, we demonstrate that three copies of other chromosome 21 genes are sufficient to partially ameliorate amyloid-β accumulation in the brain. We go on to identify a subregion of chromosome 21 that contains the gene/genes causing this decrease in amyloid-β accumulation and investigate the role of two lead candidate genes Dyrk1a and Bace2 Thus an additional copy of chromosome 21 genes, other than APP, can modulate APP/amyloid-β in the brain under physiological conditions. This work provides critical mechanistic insight into the development of disease and an explanation for the typically later age of onset of dementia in people who have AD-DS, compared to those who have familial AD caused by triplication of APP Significance Statement:Trisomy of chromosome 21 is a commonly occurring genetic risk factor for early-onset Alzheimer's disease, which has been previously attributed to people with Down syndrome having three copies of the APP gene, which is encoded on chromosome 21. However, we have shown that an extra copy of other chromosome 21 genes modifies AD-like phenotypes independently of APP copy number (Wiseman et al. 2018, Brain; Tosh et al. 2021 Scientific Reports). Here, we use a mapping approach to narrow-down the genetic cause of the modulation of pathology; demonstrating that gene(s) on chromosome 21 decrease amyloid-β accumulation in the brain, independently of alterations to full-length APP or C-terminal fragment abundance and that just 38 genes are sufficient to cause this
Recommended from our members
A multi-hit hypothesis for an APOE4-dependent pathophysiological state
The APOE gene encoding the Apolipoprotein E protein is the single most significant genetic risk factor for late-onset Alzheimer's disease. The APOE4 genotype confers a significantly increased risk relative to the other two common genotypes APOE3 and APOE2. Intriguingly, APOE4 has been associated with neuropathological and cognitive deficits in the absence of Alzheimer's disease-related amyloid or tau pathology. Here, we review the extensive literature surrounding the impact of APOE genotype on central nervous system dysfunction, focussing on preclinical model systems and comparison of APOE3 and APOE4, given the low global prevalence of APOE2. A multi-hit hypothesis is proposed to explain how APOE4 shifts cerebral physiology towards pathophysiology through interconnected hits. These hits include the following: neurodegeneration, neurovascular dysfunction, neuroinflammation, oxidative stress, endosomal trafficking impairments, lipid and cellular metabolism disruption, impaired calcium homeostasis and altered transcriptional regulation. The hits, individually and in combination, leave the APOE4 brain in a vulnerable state where further cumulative insults will exacerbate degeneration and lead to cognitive deficits in the absence of Alzheimer's disease pathology and also a state in which such pathology may more easily take hold. We conclude that current evidence supports an APOE4 multi-hit hypothesis, which contributes to an APOE4 pathophysiological state. We highlight key areas where further study is required to elucidate the complex interplay between these individual mechanisms and downstream consequences, helping to frame the current landscape of existing APOE-centric literature
A multi-disciplinary commentary on preclinical research to investigate vascular contributions to dementia
Although dementia research has been dominated by Alzheimer's disease (AD), most dementia in older people is now recognised to be due to mixed pathologies, usually combining vascular and AD brain pathology. Vascular cognitive impairment (VCI), which encompasses vascular dementia (VaD) is the second most common type of dementia. Models of VCI have been delayed by limited understanding of the underlying aetiology and pathogenesis. This review by a multidisciplinary, diverse (in terms of sex, geography and career stage), cross-institute team provides a perspective on limitations to current VCI models and recommendations for improving translation and reproducibility. We discuss reproducibility, clinical features of VCI and corresponding assessments in models, human pathology, bioinformatics approaches, and data sharing. We offer recommendations for future research, particularly focusing on small vessel disease as a main underpinning disorder
A Multi-disciplinary Commentary on Preclinical Research to investigate Vascular Contributions to Dementia
Although dementia research has been dominated by Alzheimer's disease (AD), most dementia in older people is now recognised to be due to mixed pathologies, usually combining vascular and AD brain pathology. Vascular cognitive impairment (VCI), which encompasses vascular dementia (VaD) is the second most common type of dementia. Models of VCI have been delayed by limited understanding of the underlying aetiology and pathogenesis. This review by a multidisciplinary, diverse (in terms of sex, geography and career stage), cross-institute team provides a perspective on limitations to current VCI models and recommendations for improving translation and reproducibility. We discuss reproducibility, clinical features of VCI and corresponding assessments in models, human pathology, bioinformatics approaches, and data sharing. We offer recommendations for future research, particularly focusing on small vessel disease as a main underpinning disorder.</p
Recommended from our members
Effects of APOE4 genotype and exercise on neurovascular coupling
The Apolipoprotein-e4 (APOE4) gene is the most common genetic risk factor for Alzheimer’s disease (AD) and is associated with a higher risk of cardiovascular disease. Vascular dysfunction is an early symptom of AD, suggesting it may drive disease onset. APOE4 carriers might therefore be more at risk of developing AD due to cardiovascular impairment. On the other hand, physical exercise (PE) is associated with beneficial effects on neuronal health and vascular function. I first investigated whether APOE4 mice have impaired neurovascular function and whether exercise might reverse these effects. Thy1-GCaMP6f mice expressing human APOE3/3 or APOE4/4 were implanted with a cranial window over visual cortex (V1), allowing for visualisation of neurovasculature using two-photon microscopy and recording of net haemodynamic measures using an Oxy-CBF probe. Following surgery, a cohort of mice of each genotype received an exercise wheel in the home cage, while a control group did not. PE increased vasomotion and vascular density in APOE4 mice, which otherwise showed decreased vascular density compared to APOE3 mice. APOE4 sedentary mice had less active neurons and impaired NVC even relative to this lower neuronal activity. PE enhanced vascular responses to neuronal activity and prevented the APOE4 mediated decline in neuronal function. PE also correlated with resting blood oxygen levels and the size and frequency of vascular dilations. I then investigated neurovascular changes in a model of the onset of AD. APOE3/3 and APOE4/4 mice were crossed with mice that express APPswe/ind under the control of a tetO promoter. When the mice are on a doxycycline diet (dox), APPswe/ind transcription is halted, but when they are on a normal diet, Aß, a hallmark of AD, is produced. Mice underwent a cranial window surgery with viral infusion of CaMKII-GCaMP6f in V1, to fluorescently label excitatory neurons. Neurovascular function was studied before and 4-12 weeks after triggering the production of Aß. sO2 was reduced shortly after the onset of Aß production alongside reductions in neuronal activity and vessel responsiveness, regardless of genotype. Overall, this project suggests APOE4 decreases neurovascular function prior to the onset of Aß production, but this effect is mitigated by exercise. Aß accumulation further impairs vascular function and reduces blood oxygen levels, promoting hypoxia. Targeting vascular dysfunction with exercise or pharmacologically might help prevent this pathology and reduce AD risk
Recommended from our members
Supporting Data for Gradual Not Sudden Change: Multiple Sites of Functional Transition Across the Microvascular Bed
The data provided was used to generate the figures in Shaw et al (2022); Gradual Not Sudden Change: Multiple Sites of Functional Transition Across the Microvascular Bed, Frontiers in Aging Neuroscience. Full details of how the data was generated and processed is provided in that paper. The ReadMe file attached to this record gives details on the data including measurements and column headings.A single Excel spreadsheet containing all the data points used for
graphs in Figures 4-9 and Supplementary Figures 3-6 as individual work
sheets (uploaded as .xlsx), and individual .csv files containing all the
data points used for graphs in Figures 4-9 and Supplementary Figures
2-6 (for non-proprietary format). Abstract In understanding the role of the neurovascular unit as both a biomarker
and target for disease interventions, it is vital to appreciate how the
function of different components of this unit change along the vascular
tree. The cells of the neurovascular unit together perform an array of
vital functions, protecting the brain from circulating toxins and
infection, while providing nutrients and clearing away waste products.
To do so, the brain’s microvasculature dilates to direct energy
substrates to active neurons, regulates access to circulating immune
cells, and promotes angiogenesis in response to decreased blood supply,
as well as pulsating to help clear waste products and maintain the
oxygen supply. Different parts of the cerebrovascular tree contribute
differently to various aspects of these functions, and previously, it
has been assumed that there are discrete types of vessel along the
vascular network that mediate different functions. Another option,
however, is that the multiple transitions in function that occur across
the vascular network do so at many locations, such that vascular
function changes gradually, rather than in sharp steps between clearly
distinct vessel types. Here, by reference to new data as well as by
reviewing historical and recent literature, we argue that this latter
scenario is likely the case and that vascular function gradually changes
across the network without clear transition points between arteriole,
precapillary arteriole and capillary. This is because classically
localised functions are in fact performed by wide swathes of the
vasculature, and different functional markers start and stop being
expressed at different points along the vascular tree. Furthermore,
vascular branch points show alterations in their mural cell morphology
that suggest functional specialisations irrespective of their position
within the network. Together this work emphasises the need for studies
to consider where transitions of different functions occur, and the
importance of defining these locations, in order to better understand
the vascular network and how to target it to treat disease.
<br